In The News Posted June 17, 2021 Share Posted June 17, 2021 NEW YORK, June 17, 2021 /PRNewswire/ -- Elevation Oncology, a clinical stage biopharmaceutical company focused on the development of precision medicines for patients with genomically defined cancers, announced today the appointment of Joseph Ferra as the company's Chief Financial Officer....View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.